AUGUSTA – Maine is getting $950,000 from EpiPen maker Mylan as part of a national settlement.
The company this week finalized a $465 million federal agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade.
Maine Attorney General Janet Mills called the company’s conduct “unconscionable.”
It’s the second settlement with the Department of Justice that Mylan has made since 2009 for allegedly overcharging the government. The new case involves Mylan paying Medicaid too-low rebates for the devices by classifying its brand-name product as a generic, which requires lower rebates.
Those actions are separate from another lawsuit Maine filed against Mylan for alleged price-fixing for a certain diabetes medication and an antibiotic. That lawsuit is pending.
Send questions/comments to the editors.
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have a commenting profile? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.